Image may be NSFW.
Clik here to view.
Clik here to view.
Interface in licensing pact with Navilyst Medical
Closely held Interface Biologics has reached a definitive license and supply agreement with Navilyst Medical, giving it exclusive access to incorporate Interface’s Endexo technology in its vascular...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Interface partner gets FDA okay for PICC with Endexo
Closely held Interface Biologics’ licensing partner, AngioDynamics (Nasdaq:ANGO), has been granted 510(k) clearance by the FDA for its BioFlo PICC with Interface’s Endexo technology. Endexo is a...
View Article
